File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Schizonepeta tenuifolia: Chemistry, pharmacology, and clinical applications

TitleSchizonepeta tenuifolia: Chemistry, pharmacology, and clinical applications
Authors
Issue Date2002
Citation
Journal of Clinical Pharmacology, 2002, v. 42, n. 1, p. 30-36 How to Cite?
AbstractThis article presents an up-to-date review of the plant Schizonepeta tenuifolia (Jingjie), of family Labiatae, with respect to its traditional uses, chemical constituents, various pharmacological activities, and clinical effects. Nonetheless, its mechanism of actions, adverse effects, drug interactions, and contraindications remain unclear. With the global growth on the use of herbal products, Jingjie has been commonly marketed for the treatment of common cold and fever in Chinese proprietary medicines. Hence, further studies will be warranted to show its efficacy and safety. © 2002 the American College of Clinical Pharmacology.
Persistent Identifierhttp://hdl.handle.net/10722/342998
ISSN
2023 Impact Factor: 2.4
2023 SCImago Journal Rankings: 0.717

 

DC FieldValueLanguage
dc.contributor.authorFung, D.-
dc.contributor.authorLau, C. B.S.-
dc.date.accessioned2024-05-10T09:04:39Z-
dc.date.available2024-05-10T09:04:39Z-
dc.date.issued2002-
dc.identifier.citationJournal of Clinical Pharmacology, 2002, v. 42, n. 1, p. 30-36-
dc.identifier.issn0091-2700-
dc.identifier.urihttp://hdl.handle.net/10722/342998-
dc.description.abstractThis article presents an up-to-date review of the plant Schizonepeta tenuifolia (Jingjie), of family Labiatae, with respect to its traditional uses, chemical constituents, various pharmacological activities, and clinical effects. Nonetheless, its mechanism of actions, adverse effects, drug interactions, and contraindications remain unclear. With the global growth on the use of herbal products, Jingjie has been commonly marketed for the treatment of common cold and fever in Chinese proprietary medicines. Hence, further studies will be warranted to show its efficacy and safety. © 2002 the American College of Clinical Pharmacology.-
dc.languageeng-
dc.relation.ispartofJournal of Clinical Pharmacology-
dc.titleSchizonepeta tenuifolia: Chemistry, pharmacology, and clinical applications-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1177/0091270002042001003-
dc.identifier.pmid11817365-
dc.identifier.scopuseid_2-s2.0-0036137267-
dc.identifier.volume42-
dc.identifier.issue1-
dc.identifier.spage30-
dc.identifier.epage36-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats